M. Wollemann et al., Comparison of the endogenous heptapeptide Met-enkephalin-Arg6-Phe7 bindingin amphibian and mammalian brain, ACT BIOL HU, 50(1-3), 1999, pp. 297-307
In previous communications [4, 38] we published that [H-3]Met-enkephalin-Ar
g(6)-Phe(7) (MERF) binds to opioid (kappa(2) and delta) and sigma(2) sites
in frog and rat brain membrane preparations, however no binding to kappa(1)
sites could be established. In the present paper we compare the frog, rat
and guinea pig brain membrane fractions with respect to their MERF binding
data. No qualitative differences were found between the three species but s
pecific binding of labelled MERF was maximal in frog brain and lowest in gu
inea pig brain, which corresponds to their kappa(2) opioid receptor distrib
ution. The naloxone resistant binding was also present in all investigated
species and varied from 25% in frog and guinea pig cerebrum, to 50% in rat
cerebrum and cerebellum, but no naloxone inhibition was found in guinea pig
cerebellum where no kappa(2) opioid receptors have been found. The presenc
e of sigma(2)-like receptor was demonstrated in each investigated membrane
fraction with displacement experiments using (-)N-allyl-normetazocine as co
mpetitor of tritiated MERF. It was shown that this site was responsible for
60-80% of [H-3]MERF binding. The remaining part of the naloxone resistant
labelled MERF binding could be displaced only with endogenous opioid peptid
es as met-enkephalin, dynorphin and beta-endorphin. The eventual physiologi
cal role of multiple MERF receptors is discussed.